|
1
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodeling at the cellular
level. Clin Biochem. 45:863–873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chim SM, Tickner J, Chow ST, Kuek V, Guo
B, Zhang G, Rosen V, Erber W and Xu J: Angiogenic factors in bone
local environment. Cytokine Growth Factor Rev. 24:297–310. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parfitt AM: Targeted and nontargeted bone
remodeling: Relationship to basic multicellular unit origination
and progression. Bone. 30:5–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirano T, Yasukawa K, Harada H, Taga T,
Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K,
Iwamatsu A, et al: Complementary DNA for a novel human interleukin
(BSF-2) that induces B lymphocytes to produce immunoglobulin.
Nature. 324:73–76. 1986. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kwan TS, Padrines M, Théoleyre S, Heymann
D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone
resorption pathophysiology. Cytokine Growth Factor Rev. 15:49–60.
2004. View Article : Google Scholar
|
|
6
|
Prystaz K, Kaiser K, Kovtun A,
Haffner-Luntzer M, Fischer V, Rapp AE, Liedert A, Strauss G,
Waetzig GH, Rose-John S and Ignatius A: Distinct effects of IL-6
classic and trans-signaling in bone fracture healing. Am J Pathol.
188:474–490. 2018. View Article : Google Scholar
|
|
7
|
Sims NA: Cell-specific paracrine actions
of IL-6 family cytokines from bone, marrow and muscle that control
bone formation and resorption. Int J Biochem Cell Biol. 79:14–23.
2006. View Article : Google Scholar
|
|
8
|
Schopf FH, Biebl MM and Buchner J: The
HSP90 chaperone machinery. Nat Rev Mol Cell Biol. 18:345–360. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiosis G: Targeting chaperones in
transformed systems-a focus on Hsp90 and cancer. Expert Opin Ther
Targets. 10:37–50. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prodromou C: Mechanisms of Hsp90
regulation. Biochem J. 473:2439–2452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu W and Neckers L: Targeting the
molecular chaperone heat shock protein 90 provides a multifaceted
effect on diverse cell signaling pathways of cancer cells. Clin
Cancer Res. 13:1625–1629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Whitesell L and Lindquist SL: HSP90 and
the chaperoning of cancer. Nat Rev Cancer. 5:761–772. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schulte TW and Neckers LM: The
benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds
to HSP90 and shares important biologic activities with
geldanamycin. Cancer Chemother Pharmacol. 42:273–279. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jez JM, Chen JC, Rastelli G, Stroud RM and
Santi DV: Crystal structure and molecular modeling of 17-DMAG in
complex with human Hsp90. Chem Biol. 10:361–368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ochel HJ, Eichhorn K and Gademann G:
Geldanamycin: The prototype of a class of antitumor drugs targeting
the heat shock protein 90 family of molecular chaperones. Cell
Stress Chaperones. 6:105–112. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Price JT, Quinn JM, Sims NA, Vieusseux J,
Waldeck K, Docherty SE, Myers D, Nakamura A, Waltham MC, Gillespie
MT and Thompson EW: The heat shock protein 90 inhibitor,
17-allylamino-17-demethoxygeldanamycin, enhances osteoclast
formation and potentiates bone metastasis of a human breast cancer
cell line. Cancer Res. 65:4929–4938. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mori M, Hitora T, Nakamura O, Yamagami Y,
Horie R, Nishimura H and Yamamoto T: Hsp90 inhibitor induces
autophagy and apoptosis in osteosarcoma cells. Int J Oncol.
46:47–54. 2015. View Article : Google Scholar
|
|
18
|
Fujita K, Tokuda H, Kuroyanagi G, Yamamoto
N, Kainuma S, Kawabata T, Sakai G, Matsushima-Nishiwaki R, Kozawa O
and Otsuka T: HSP90 inhibitors potentiate PGF2α-induced IL-6
synthesis via p38 MAPK in osteoblasts. PLoS One. 12:e01778782017.
View Article : Google Scholar
|
|
19
|
Kyriakis JM and Avruch J: Mammalian
mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol Rev. 81:807–869.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lane DA, Philippou H and Huntington JA:
Directing thrombin. Blood. 106:2605–2612. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mackie EJ, Loh LH, Sivagurunathan LS,
Uaesoontrachoon K, Yoo HJ, Wong D, Georgy SR and Pagel CN:
Protease-activated receptors in the musculoskeletal system. Int J
Biochem Cell Biol. 40:1169–1184. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kozawa O, Tokuda H, Kaida T, Matsuno H and
Uematsu T: Thrombin regulates interleukin-6 synthesis through
phosphate-dylcholine hydrolysis by phospholipase D in osteoblasts.
Arch Biochem Biophys. 345:10–15. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kato K, Otsuka T, Matsushima-Nishiwaki R,
Natsume H, Kozawa O and Tokuda H: Rho-kinase regulates
thrombin-stimulated interleukin-6 synthesis via p38
mitogen-activated protein kinase in osteoblasts. Int J Mol Med.
28:653–658. 2011.PubMed/NCBI
|
|
24
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2 in
osteoblast-like cells. Exp Cell Res. 198:130–134. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells.
J Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen H, Xing J, Hu X, Chen L, Lv H, Xu C,
Hong D and Wu X: Inhibition of heat shock protein 90 rescues
glucocorticoid-induced bone loss through enhancing bone formation.
J Steroid Biochem Mol Biol. 171:236–246. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fukata Y, Amano M and Kaibuchi K:
Rho-Rho-kinase pathway in smooth muscle contraction and
cytoskeletal reorganization of non-muscle cells. Trends Pharmacol
Sci. 22:32–39. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ito M, Nakano T, Erdori F and Hartshorne
DJ: Myosin phosphatase: Structure, regulation and function. Mol
Cell Biochem. 259:197–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cuenda A, Rouse J, Doza YN, Meier R, Cohen
P, Gallagher TF, Young PR and Lee JC: SB 203580 is a specific
inhibitor of a MAPK homologue which is stimulated by cellular
stresses and interleukin-1. FEBS Lett. 364:229–233. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kozawa O, Niwa M, Hatakeyama D, Tokuda H,
Oiso Y, Matsuno H, Kato K and Uematsu T: Specific induction of heat
shock protein 27 by glucocorticoid in osteoblasts. J Cell Biochem.
86:357–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verma S, Goyal S, Jamal S, Singh A and
Grover A: Hsp90: Friends, clients and natural foes. Biochimie.
127:227–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
